A double-blind, comparative study of nonanimal-stabilized hyaluronic acid versus human collagen for tissue augmentation of the dorsal hands. [2008.08]
Understanding, avoiding, and managing dermal filler complications. [2008.06]
Randomized, evaluator-blind, split-face comparison study of single cross-linked versus double cross-linked hyaluronic acid in the treatment of glabellar lines. [2008.06]
Persistence and improvement of nasolabial fold correction with nonanimal-stabilized hyaluronic acid 100,000 gel particles/mL filler on two retreatment schedules: results up to 18 months on two retreatment schedules. [2008.06]
Effect of injection techniques on the rate of local adverse events in patients implanted with nonanimal hyaluronic acid gel dermal fillers. [2008.06]
Anatomic location of hyaluronic acid filler material injected into nasolabial fold: a histologic study. [2008.06]
A comparison of commercially available polymethylmethacrylate-based soft tissue fillers. [2008.06]
Complications after polymethylmethacrylate injections: report of 32 cases. [2008.05]
Advances in facial rejuvenation: botulinum toxin type a, hyaluronic acid dermal fillers, and combination therapies--consensus recommendations. [2008.05]
The science of hyaluronic acid dermal fillers. [2008.03]
Risk profiles of different injectable fillers: results from the Injectable Filler Safety Study (IFS Study). [2008.03]
Patient-preferred sites of restylane injection in periocular and facial soft-tissue augmentation. [2008.03]
Non-hyaluronic acid fillers. [2008.03]
Delayed immune-mediated adverse effects related to hyaluronic acid and acrylic hydrogel dermal fillers: clinical findings, long-term follow-up and review of the literature. [2008.02]
Effectiveness of Juvederm Ultra Plus dermal filler in the treatment of severe nasolabial folds. [2008.01]
A randomized, evaluator-blinded comparison of efficacy of hyaluronic acid gel and avian-sourced hylan B plus gel for correction of nasolabial folds. [2007.08]
A novel method to inject hyaluronic acid: the Fern Pattern Technique. [2007.08]
Management of visible granulomas following periorbital injection of poly-L-lactic Acid. [2007.07]
A two-stage phase I trial of Evolence30 collagen for soft-tissue contour correction. [2007.07]
Autologous cultured fibroblast injection for facial contour deformities: a prospective, placebo-controlled, Phase III clinical trial. [2007.03]
Adverse effects when injecting facial fillers. [2007.03]
Technique for calcium hydroxylapatite injection for correction of nasolabial fold depressions. [2007.02]
Injectable soft-tissue fillers: clinical overview. [2006.09.15]
Soft-tissue augmentation and the role of poly-L-lactic acid. [2006.09]
Evaluation of a calcium hydroxylapatite-based implant (Radiesse) for facial soft-tissue augmentation. [2006.09]
Avoiding and treating dermal filler complications. [2006.09]
ArteFill: a long-lasting injectable wrinkle filler material--summary of the U.S. Food and Drug Administration trials and a progress report on 4- to 5-year outcomes. [2006.09]
Injectable hyaluronic acid implant for malar and mental enhancement. [2006.07]
Injectable treatments for the aging face. [2006.05]
Hyaluronic acid gel (Restylane) filler for facial rhytids: lessons learned from American Society of Ophthalmic Plastic and Reconstructive Surgery member treatment of 286 patients. [2006.05]
ArteFill: a permanent skin filler. [2006.05]
Effect of monopolar radiofrequency treatment over soft-tissue fillers in an animal model: part 2. [2006.03]
Cutaneous sarcoidal granulomas developing after Artecoll facial cosmetic filler in a patient with newly diagnosed systemic sarcoidosis. [2006.03]
Consensus recommendations for soft-tissue augmentation with nonanimal stabilized hyaluronic acid (Restylane). [2006.03]
Techniques for soft tissue augmentation: an 'a to z'. [2006]
Use of hyaluronidase in the treatment of granulomatous hyaluronic acid reactions or unwanted hyaluronic acid misplacement. [2005.08]
Injected hyaluronidase reduces restylane-mediated cutaneous augmentation. [2005.07]
Filling agents. [2005.06]
Scar sarcoidosis after hyaluronic acid injection. [2005.05]
The evolution of soft tissue fillers in clinical practice. [2005.04]
Soft tissue implants and fillers. [2005.04]
Injectable skin fillers. [2005.04]
Safety and efficacy of nonanimal stabilized hyaluronic acid for improvement of mouth corners. [2005.03]
Managing inflammatory reaction to restylane. [2005.03]
Clinical Use of RESTYLANE. [2005.02]
Midface volume replacement with a transmaxillary implant. [2005.01]
A randomized, evaluator-blind, multicenter comparison of the efficacy and tolerability of Perlane versus Zyplast in the correction of nasolabial folds. [2005.01]
The use of poly-L-lactic acid in the management of soft-tissue augmentation: a five-year experience. [2004.12]
The histological aspects of fillers complications. [2004.12]
1 2 Next >>
